​
​

Agile Therapeutics Ownership | Who Owns Agile Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Agile Therapeutics Ownership Summary

100.00% retail investors. SSgA U.S. Extended Market Index Class I is the top mutual fund, with 0.00% of its assets in Agile Therapeutics shares.

AGRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAgile Therapeutics--100.00%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustrySpecialty & Generic Drug Manufacturers Stocks33.38%9.20%57.42%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20231-10---1---
Mar 31, 202235-25.53%40,559,7797.73%322.16%16-27.27%7-46.15%
Dec 31, 202147-12.96%37,651,15318.45%383.62%2269.23%13-40.91%
Sep 30, 202154-25.00%31,787,149-7.56%321.99%13-60.61%22-12.00%
Jun 30, 202172-10.00%34,385,876-10.17%401.99%33-25-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
SSgA U.S. Extended Market Index Class I15.000.00%-
NT US Market Cap Idx Fd - L5.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 26, 2022ALTOMARI ALFRED Chief Executive OfficerBuy$22.50K
Oct 13, 2021PERCEPTIVE ADVISORS LLC-Buy$2.28M
Oct 13, 2021PERCEPTIVE ADVISORS LLC-Buy$4.87M
Oct 13, 2021Reilly Dennis Chief Financial OfficerBuy$25.00K
Oct 13, 2021Reilly Dennis Chief Financial OfficerBuy$50.00K

Insider Transactions Trends

DateBuySell
2024 Q3--
2023 Q4--
2023 Q3--
2023 Q2--
2022 Q4--

AGRX Ownership FAQ

Who Owns Agile Therapeutics?

Agile Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Agile Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 33.38%, which Agile Therapeutics falls below.

Does Blackrock own Agile Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Agile Therapeutics.

Who is the top mutual fund holder of Agile Therapeutics shares?

SSgA U.S. Extended Market Index Class I is the top mutual fund holder of Agile Therapeutics shares, with 0.00% of its total shares outstanding invested in 15 Agile Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools